Literature DB >> 10701815

Racial differences in response to acute dosing with hydrochlorothiazide.

E Ripley1, K King, D A Sica.   

Abstract

Blacks demonstrate a higher response rate to diuretic therapy for hypertension than do whites. This study examined the pharmacokinetic (PK), pharmacodynamic, and neurohumoral effects of hydrochlorothiazide (HCTZ) administration in a matched group of 9 black and 9 white hypertensive patients (mean +/- SD for black and white). After a 4-week washout period and 7-day control diet, subjects received a single dose of HCTZ (25 mg at 8 AM) with serial blood and urine collections for 36 hours. After HCTZ sodium excretion increased comparably in both groups (blacks: 122 +/- 42 pre to 265 +/- 49 mEq/24 hours post; whites: 117 +/- 29 pre to 255 beta 39 mEq/24 hrs post). Potassium excretion tended to be higher at baseline and was significantly higher following HCTZ in whites (blacks: 45 beta 20 pre to 66 beta 13 mEq at 24 hours post; blacks: 57 +/- 9 pre to 86 +/- 14 mEq at 24 hours post) with most of the post-dosing difference being observed in the hours 0 to 12 after HCTZ. There were no between group PK differences for urinary HCTZ. Aldosterone excretion followed a normal circadian pattern in the whites but did not show this pattern in the blacks. Aldosterone excretion (0 to 12 hours) was generally lower post-dosing in blacks. In conclusion, whereas the PK and single-dose natriuretic response for HCTZ were not racially distinct, potassium excretion was notably less in blacks. Aldosterone excretion was also lower in blacks and without its normal circadian pattern which may, in part, explain their altered potassium excretion pattern.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701815     DOI: 10.1016/s0895-7061(99)00168-5

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Racial differences in sensitivity of blood pressure to aldosterone.

Authors:  Wanzhu Tu; George J Eckert; Tamara S Hannon; Hai Liu; Linda M Pratt; Mary Anne Wagner; Linda A Dimeglio; Jeesun Jung; J Howard Pratt
Journal:  Hypertension       Date:  2014-04-07       Impact factor: 10.190

Review 2.  Trends in 24-h urinary sodium excretion in the United States, 1957-2003: a systematic review.

Authors:  Adam M Bernstein; Walter C Willett
Journal:  Am J Clin Nutr       Date:  2010-09-08       Impact factor: 7.045

3.  Dysregulated aldosterone secretion in persons of African descent with endothelin-1 gene variants.

Authors:  Jia W Tan; Tina Gupta; Worapaka Manosroi; Tham M Yao; Paul N Hopkins; Jonathan S Williams; Gail K Adler; Jose R Romero; Gordon H Williams
Journal:  JCI Insight       Date:  2017-12-07

Review 4.  Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension.

Authors:  Caroline Fenton; Gillian M Keating; Lesley J Scott
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Clinical and neurohormonal characteristics in African Americans with neurogenic orthostatic hypotension.

Authors:  Richard J Giza; Maureen C Farrell; Amy C Arnold; Italo Biaggioni; Cyndya A Shibao
Journal:  Clin Auton Res       Date:  2021-01-27       Impact factor: 5.625

Review 6.  Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review.

Authors:  Lizzy M Brewster; Yackoob K Seedat
Journal:  BMC Med       Date:  2013-05-30       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.